Marksans Pharma has informed that the Meeting of the Board of Directors of the Company will be held on Monday, 13th November, 2017 at Mumbai, to consider and approve the Unaudited Financial Results of the Company (both Standalone and Consolidated) for the quarter ended 30th September, 2017.
The above information is a part of company’s filings submitted to BSE.